Rapid advances in science and medicine have made constant innovation a critical business practice for biotechnology companies, according to Paul Perreault, CEO and Managing Director of CSL, the world’s fifth-largest biotech.
Get the latest stories from Vita by signing up for our newsletter.
During a recent visit to the campus of Pennsylvania State University, Perreault sat down with Carolyn Donaldson from NPR affiliate WPSU for an in-depth discussion on the state of biotech and how innovation is driving the industry.
“In our space, if you're not innovating, you're managing your exit,” Perreault said. “So that's what we're trying to really drive within the organization is the sense that we're here to deliver for patients.”
To hear Perreault’s interview, head to WPSU.org.
Perreault visited Penn State in March to deliver remarks on Innovation in Biotech. The speech followed last year’s opening of the CSL Behring Fermentation Facility on the Penn State campus.
